BioCryst Pharmaceuticals Inc. - Latest News
Current status: normal - monitoring
Number of users monitoring this page: 1
Most recent sizable change (text, html) : 2012-02-06 08:13
Most recent change (text, html) : 2012-02-08 08:12
Last checked for changes: 2012-02-14 08:52
ChangeDetection started monitoring: 2009-10-03 08:11
|
monitor this page
summary of most recent changes
|
Showing 1 - 5 of 9
|
1 2 [next]
|
|
|
View changes:
2012-02-06 08:13
87 new words, 83 deleted words, 9% change
|
|
... 2008 2007 All Releases BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 Feb 6, 2012 11.9 KB RESEARCH TRIANGLE PARK, N ... , February 16, 2012. BioCryst will host a conference call and webcast at 11:00 a.m. Eastern Time to discus... Read more Nancy Hutson Appointed to ... Ly... Read more BioCryst Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011 Apr 25, 2011 12.7 KB RESEARCH TRIANGLE PARK, N. ...
2008 2007 All Releases BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 Feb 6, 2012 11.9 KB RESEARCH TRIANGLE PARK, N ... , February 16, 2012. BioCryst will host a conference call and webcast at 11:00 a.m. Eastern Time to discus... Read more Nancy Hutson Appointed to ... Showing 1-20 of 145
2008 2007 All Releases ... Ly... Read more BioCryst Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011 Apr 25, 2011 12.7 KB RESEARCH TRIANGLE PARK, N. ... . BioCryst will host a conference call and webcast at 11:00 a.m. Eastern Time to discuss the financial results and... Read more Showing 1-20 of 145
more...
|
|
View changes:
2012-01-19 08:35
82 new words, 81 deleted words, 9% change
|
|
... 2008 2007 All Releases Nancy Hutson Appointed to BioCryst's Board of Directors Jan 19, 2012 ... KB RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that ... Nancy onboard and welcome her to the BioC... Read more BioCryst Announces Positive Results from ... and... Read more BioCryst to Present New BCX4208 Gout Results at the Annual ... ...
2008 2007 All Releases Nancy Hutson Appointed to BioCryst's Board of Directors Jan 19, 2012 ... KB RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that ... Nancy onboard and welcome her to the BioC... Read more BioCryst Announces Positive Results from ... Showing 1-20 of 147 Page: 1 2
2008 2007 All Releases ... and... Read more BioCryst to Present New BCX4208 Gout Results at the Annual ... League Against Rheumatism (EULAR) in London... Read more Showing 1-20 of 146 Page: 1 2
more...
|
|
View changes:
2012-01-09 09:08
70 new words, 85 deleted words, 9% change
|
|
... Year: All Years 2012 2011 2010 2009 2008 2007 All Releases BioCryst Announces Positive Results from Its Ongoing BCX4208 Phase 2B Study in Patients with Gout Jan 8, 2012 20.1 ... a conference call & webcast Monday, January 9 at 10:00 a.m. ET RESE... Read more BioCryst Pharmaceuticals Presents New BCX ... London... Read more BioCryst Announces Close of $30 Million Financing Transaction Related to Future RAPIACTA ( R ) Payments Mar 9, ...
Year: All Years 2012 2011 2010 2009 2008 2007 All Releases BioCryst Announces Positive Results from Its Ongoing BCX4208 Phase 2B Study in Patients with Gout Jan 8, 2012 20.1 ... a conference call & webcast Monday, January 9 at 10:00 a.m. ET RESE... Read more BioCryst Pharmaceuticals Presents New BCX ... Showing 1-20 of 147 Page: 1 2
Year: All Years ... London... Read more BioCryst Announces Close of $30 Million Financing Transaction Related to Future RAPIACTA ( R ) Payments Mar 9, ... ) payments from Shionogi & Co., Ltd. BioCryst intends to use its net proceeds receive... Read more Showing 1-20 of 146 Page: 1 2
more...
|
|
2011-11-08 09:51
83 new words, 68 deleted words, 8% change
|
|
... All Releases BioCryst Pharmaceuticals Presents New BCX4208 Gout Data at the 2011 ACR/ARHP Annual Scientific Meeting Nov 8, 2011 19.2 KB BioCryst to ... new results today from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in... Read more BioCryst Pharmaceuticals Provides Corporate Update and ... receive... Read more BioCryst to Present at Two Upcoming Investor Conferences Feb 28, 2011 10.8 KB RESEARCH TRIANGLE PARK, N.C.--(BUSINESS ...
All Releases BioCryst Pharmaceuticals Presents New BCX4208 Gout Data at the 2011 ACR/ARHP Annual Scientific Meeting Nov 8, 2011 19.2 KB BioCryst to ... new results today from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in... Read more BioCryst Pharmaceuticals Provides Corporate Update and ... Showing 1-20 of 153
All Releases BioCryst Pharmaceuticals ... receive... Read more BioCryst to Present at Two Upcoming Investor Conferences Feb 28, 2011 10.8 KB RESEARCH TRIANGLE PARK, N.C.--(BUSINESS ... and provide a corporate summary and update regarding the Company’s clinical programs at the following investor conferences: ... Read more Showing 1-20 of 153
|
|
2011-11-02 09:31
81 new words, 84 deleted words, 9% change
|
|
... All Releases BioCryst Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2011 Financial Results Nov 2, 2011 24.7 KB RESEARCH TRIANGLE PARK, N.C.--( ... pleased with the recent results of our 12-week Phase 2b gout study, which showed that addi... Read more BioCryst Pharmaceuticals Announces New BCX4208 ... : ... Read more BioCryst Awarded Additional $55.0 Million by the U.S. Department of Health & Human Services to Complete Peramivir Phase 3 ...
All Releases BioCryst Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2011 Financial Results Nov 2, 2011 24.7 KB RESEARCH TRIANGLE PARK, N.C.--( ... pleased with the recent results of our 12-week Phase 2b gout study, which showed that addi... Read more BioCryst Pharmaceuticals Announces New BCX4208 ... Showing 1-20 of 154
All Releases BioCryst Pharmaceuticals ... : ... Read more BioCryst Awarded Additional $55.0 Million by the U.S. Department of Health & Human Services to Complete Peramivir Phase 3 ... N.C.--(BUSINESS WIRE)-- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that... Read more Showing 1-20 of 154
|
link to this change log
Changes to the page investor.shareholder.com/biocryst/latestnews.cfm are logged on this page as they are detected. You can link to this log
by pasting the HTML below into your page. It produces a link which looks like this: change log
|
|
